Neuromuscular blocking agents and carotid body oxygen sensing.
Jonsson
Malin
M
Department of Anesthesiology and Intensive Care Medicine, Karolinska Hospital and Institute, Stockholm, Sweden.
Lindahl
Sten G E
SG
Eriksson
Lars I
LI
D000818:Animals; D001279:Atracurium / Q000494:pharmacology; D002344:Carotid Body / Q000187:drug effects* / Q000378:metabolism* / Q000502:physiology; D006801:Humans; D000860:Hypoxia / Q000378:metabolism / Q000503:physiopathology; D066298:In Vitro Techniques; D009125:Muscle Relaxants, Central / Q000494:pharmacology; D009466:Neuromuscular Blocking Agents / Q000494:pharmacology*; D003473:Neuromuscular Nondepolarizing Agents / Q000494:pharmacology; D009538:Nicotine / Q000494:pharmacology; D010100:Oxygen / Q000378:metabolism*; D011817:Rabbits; D011950:Receptors, Cholinergic / Q000187:drug effects; D012119:Respiration / Q000187:drug effects; D009435:Synaptic Transmission / Q000187:drug effects; D014673:Vecuronium Bromide / Q000494:pharmacology
D009125:Muscle Relaxants, Central; D009466:Neuromuscular Blocking Agents; D003473:Neuromuscular Nondepolarizing Agents; D011950:Receptors, Cholinergic; D001279:Atracurium; D009538:Nicotine; D014673:Vecuronium Bromide; D010100:Oxygen